Nature CommunicationsNeurosciencePeer-reviewed journal article
Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson's Disease Brain
Jenny HällqvistiD, Christina E. ToomeyiD, Rui Climaco PintoiD, Tomas BaldwiniD, Ivan DoykoviD, Anna I. WernickiD, Mesfer Mohammad Al ShahraniiD, James R. EvansiD, Joanne LachicaiD, Simon A. S. PopeiD, Simon HealesiD, Simon D. EatoniD, Kevin A. MillsiD, Sonia GandhiiD, Wendy HeywoodiD
Abstract
Parkinsons Disease (PD) is an increasingly prevalent condition within the aging population. PD can be attributed to rare genetic mutations, but most cases are sporadic where the gene-environment interactions are unknown/likely contributory. Age related dysregulation of the glycosphingolipid degradation pathway has been implicated in the development of PD, however, our understanding of how brain lipids vary across different regions of the brain, with age and in disease stages, remains limited. In this study we profiled several phospho- and sphingolipid classes in eight distinct regions of the human brain and investigated the association of lipids with a spatio-temporal pathology gradient, utilising PD samples from early, mid, and late stages of the disease. We performed high-precision tissue sampling in conjunction with targeted LC-MS/MS and applied this to post-mortem samples from PD and control subjects. The lipids were analysed for correlations with untargeted proteomics and mitochondrial activity data, in a multi-omics approach. We concluded that the different brain regions demonstrated their own distinct profiles and also found that several lipids were correlated with age. The strongest differences between PD and controls were identified in ganglioside, sphingomyelin and n-hexosylceramides. Sphingomyelin was also found to correlate with several proteins implicated in Parkinsons disease pathways. Mitochondrial activity was correlated with the levels of several lipids in the putamen region. Finally, we identified a gradient corresponding to Braaks disease spread across the brain regions, where the areas closer to the brainstem/substantia nigra showed alterations in PC, LPC and glycosphingolipids, while the cortical regions showed changes in glycosphingolipids, specifically gangliosides, HexCer and Hex2Cer. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=116 SRC="FIGDIR/small/604051v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@d4851eorg.highwire.dtl.DTLVardef@6f9d00org.highwire.dtl.DTLVardef@1ac9d7dorg.highwire.dtl.DTLVardef@197808e_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: metabolomics
- research focus: differential expression
- approach: statistical model
- Citations
- 20
- FWCI
- 12.10
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Shared and Distinct Lipid Profiles in amygdala from Sporadic and GBA-associated Parkinson's Diseases
Sonia Sanz Muñoz, Frederik Ravnkilde Marlet, … Céline Galvagnion·npj Parkinson s DiseasePeer-reviewed·May 11, 2026
- Integrative lipidomics of brain and plasma uncovers sex-specific metabolic signatures in Parkinson's disease
Unnati Agrawal, Priya Nataraj, … Poonam Singh Thakur·bioRxiv·Oct 2, 2025
- GPNMB and glycosphingolipid measurements in cerebrospinal fluid and plasma from Parkinson's disease patients
María E. Fernández‐Suárez, Reuben Bush, … Frances M. Platt·bioRxiv·May 18, 2026
- Plasma Extracellular Vesicle Lipidomics Reveals an SMPD1-Driven Sphingomyelin Salvage Pathway Collapse in Parkinson's Disease
Sanskriti Rai, Astha Chaubey, … Saroj Kumar·bioRxiv·Sep 28, 2026
- Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease
Cheryl E. G. Leyns, Alice Prigent, … Michael X. Henderson·npj Parkinson s DiseasePeer-reviewed·May 11, 2023
- Lipid levels correlate with neuronal and dopaminergic markers during the differentiation of SH-SY5Y cells
F. R. Marlet, S. S. Munoz, … C. Galvagnion·bioRxiv·Sep 1, 2023